Equity analysts

The information contained herein either has been provided by analyst or is available to the public and BBVA make no representation or warranty, express or implied, as to the accuracy or completeness of the referred information.

BBVA reserves the right to modify or supplement the information provided without prior notice.

This data, that is not under the obligation to disclose information required by the Comisión Nacional del Mercado de Valores (CNMV), is provided as a courtesy and for convenience and informational purposes only and is not intended to imply any endorsement of or provide any investment advice.

BBVA shall have no liability whatsoever (in negligence or otherwise) for any damage or loss howsoever arising from any use of this information.

Consensus of estimated quarterly results. Consolidated

Consensus (€Mn)4Q25
Net Interest Income6,805
Gross Income9,514
Operating Income5,662
Net Attributable Profit2,556
CET1 (%) 12.91

(*) This consensus includes the estimates of 20 analysts for the P&L and CET1 ratio. Updated as of January 23rd, 2026.

Consensus of estimated annual results. Business areas

Net Attributable Profit by division (EUR Mm)4Q25
Spain950
Mexico1,331
Turkey260
South America185
Rest of Business147
Corporate Center-318

(*) This consensus includes the estimates of 20 analysts. Updated as of January 23rd, 2026.

Consensus of estimated annual results. Consolidated

Consensus (EUR m) (*)202520262027
Net Interest Income
26,00027,22528,654

Gross Income36,53838,44540,333
Operating Income22,35623,70725,095
Net Attributable Profit 10,51911,15811,906
CET1 (%)13.1312.8212.80

(*) Consensus calculated from the contribution of 17 analysts. Data updated as of November 21, 2025.

Consensus of estimated annual results. Business areas

Net Attributable Profit (EUR m) (*)202520262027
Spain4,0824,1614,368
Mexico5,1735,3525,582
Turkey9151,0901,247
South America746847932
Rest of Business636706789
Corporate Center-1,032-998-1,012

(*) Consensus calculated from the contribution of 17 analysts. Data updated as of November 21, 2025.

Consensus of estimated annual results. Exchange rates

Exchange rates (*)202520262027
Mexico (MXN/EUR)21.5622.3322.97
Turkey (TRY/EUR)49.0760.9271.50
Argentina (ARS/EUR)1.6811.9482.044
Colombia (COP/EUR)4.6314.7924.934
Peru (PEN/EUR)4.104.174.23

(*) Consensus calculated with the estimates of 14 analysts for Mexican peso, 13 for Turkish lira and 9 for the remaining currencies. Average excange rate except for hyperinflationary economies (end of period for the Turkish lira and Argentine peso).

To our best knowledge, the following analysts and companies follow BBVA on a regular basis. BBVA takes no responsibility for their opinions.

CompanyAnalyst
Alantra EquitiesFrancisco Riquel
Autonomous ResearchBritta Schmidt
Banco SabadellMaría Paz Ojeda
BankinterRafael Alonso
Bank of AmericaAntonio Reale
Barclays CapitalCecilia Romero
BestinverJavier Beldarrain
CaixaBank BPICarlos Joaquim Peixoto
CarraighillSeamus Murphy
CitigroupMarta Sánchez Romero
Deutsche Bank Alfredo Alonso
Exane BNP ParibasIgnacio Ulargui
Goldman SachsChris Hallam
GVC GaescoMarisa Mazo
Intesa SanpaoloFernando Gil de Santivañes
JB CapitalMaksym Mishyn
JefferiesÍñigo Vega
JP MorganKian Abouhossein
KBWHugo Cruz
Kepler CheuvreuxMaría Antonia Casado
MediobancaAndrea Filtri
Morgan StanleyÁlvaro Serrano
MorningstarJohann Scholtz
OddoSteven Gould
RBCBenjamin Toms
RedburnGonzalo López
Renta 4Nuria Álvarez
SantanderIgnacio Méndez
UBSIgnacio Cerezo

(*) To the best of our knowledge, the sell-side analysts listed above cover BBVA on a regular basis. The list may not be complete and may change from time to time. We update the list periodically, based on the most complete information we have at all times.

Analyst recommendations

Including equity analyst recommendation on BBVA.

Analyst recommendations

CompanyRecommendationT.PDate
Alantra EquitiesBUY23.6001/13/2026
AutonomousBUY24.0001/14/2026
Bank of AmericaBUY24.3001/09/2026
BankinterBUY20.5011/05/2025
Barclays Capital BUY22.1001/20/2026
BestinverBUY22.4001/21/2026
Caixabank BPISELL20.5001/19/2026
CarraighillBUYNR01/23/2026
CitigroupBUY23.5001/19/2026
Deutsche BankBUY19.7512/03/2025
Exane BNP ParibasSELL18.0001/21/2026
Goldman SachsBUY24.5012/19/2025
GVC GaescoBUY18.0008/01/2025
Intesa SanpaoloHOLD17.4011/06/2025
JB CapitalHOLD20.5001/12/2026
JefferiesBUY21.0011/18/2025
JP MorganBUY23.5001/19/2026
Keefe B&WBUY22.5201/13/2026
Kepler CheuvreuxHOLD21.0001/20/2026
MediobancaHOLD18.7011/26/2025
Morgan StanleyHOLD20.7001/05/2026
MorningstarHOLD17.0010/31/2025
OddoBUY21.8012/22/2025
RBCBUY19.2511/04/2025
RedburnHOLDNR10/30/2025
Renta 4SELL17.4501/20/2026
SabadellNRNR05/09/2024
UBSBUY22.7001/13/2026

(*) To the best of our knowledge, the sell-side analysts listed above cover BBVA on a regular basis. The list may not be complete and may change from time to time. We update the list periodically, based on the most complete information we have at all times.

(*) NR = Not Rated

Including equity analyst recommendation on BBVA.

Analyst recommendations

CompanyRecommendationT.PDate
Alantra EquitiesBUY23.6001/13/2026
AutonomousBUY24.0001/14/2026
Bank of AmericaBUY24.3001/09/2026
BankinterBUY20.5011/05/2025
Barclays Capital BUY22.1001/20/2026
BestinverBUY22.4001/21/2026
Caixabank BPISELL20.5001/19/2026
CarraighillBUYNR01/23/2026
CitigroupBUY23.5001/19/2026
Deutsche BankBUY19.7512/03/2025
Exane BNP ParibasSELL18.0001/21/2026
Goldman SachsBUY24.5012/19/2025
GVC GaescoBUY18.0008/01/2025
Intesa SanpaoloHOLD17.4011/06/2025
JB CapitalHOLD20.5001/12/2026
JefferiesBUY21.0011/18/2025
JP MorganBUY23.5001/19/2026
Keefe B&WBUY22.5201/13/2026
Kepler CheuvreuxHOLD21.0001/20/2026
MediobancaHOLD18.7011/26/2025
Morgan StanleyHOLD20.7001/05/2026
MorningstarHOLD17.0010/31/2025
OddoBUY21.8012/22/2025
RBCBUY19.2511/04/2025
RedburnHOLDNR10/30/2025
Renta 4SELL17.4501/20/2026
SabadellNRNR05/09/2024
UBSBUY22.7001/13/2026

(*) To the best of our knowledge, the sell-side analysts listed above cover BBVA on a regular basis. The list may not be complete and may change from time to time. We update the list periodically, based on the most complete information we have at all times.

(*) NR = Not Rated